← Back to headlines
MiNK Therapeutics Reports GAAP EPS Beat at -$0.56
MiNK Therapeutics announced its GAAP EPS of -$0.56, beating analyst estimates by $0.12.
31 Mar, 11:34 — 31 Mar, 11:34
Sources
Showing 1 of 1 sources
MiNK Therapeutics announced its GAAP EPS of -$0.56, beating analyst estimates by $0.12.
